Lion, Maëva <br/><br/>
Trastuzumab as a preoperative monotherapy does not inhibit HER2 downstream signaling in HER2-positive breast cancer.  [electronic resource] 

 -  Oncology letters  Sep 2016 
 - 2028-2032 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1792-1074 
<br/><br/><label>Standard No.: </label>10.3892/ol.2016.4891  doi